Viewing StudyNCT00866177



Ignite Creation Date: 2024-05-05 @ 9:20 PM
Last Modification Date: 2024-10-26 @ 10:03 AM
Study NCT ID: NCT00866177
Status: COMPLETED
Last Update Posted: 2015-08-11
First Post: 2009-03-19

Brief Title: MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-03
Start Date Type: None
Primary Completion Date: 2013-09
Primary Completion Date Type: ACTUAL
Completion Date: 2013-09
Completion Date Type: ACTUAL
First Submit Date: 2009-03-19
First Submit QC Date: March 19 2009
Study First Post Date: 2009-03-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-08-11
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-07-16
Last Update Post Date: 2015-08-11
Last Update Post Date Type: ESTIMATED